Atlas Trials

Steroid Refractory GVHD

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Steroid Refractory GVHD

RecordFirmDate
MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients (NCT04769895)MaaT Pharma2022-03-25
Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013 (NCT05017688)MaaT Pharma2021-10-06
Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD (NCT04289103)ElsaLys Biotech2021-10-01
ECP Combination Study (NCT05052385)European Society for Blood and Marrow Transplantation2021-04-13
Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease (NCT04070781)Columbia University2020-01-20
Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease (NCT05663827)Yi-Lun Wang2019-01-01
Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease (NCT01485055)Nationwide Children's Hospital2011-12-01
Early Access Program With MaaT013 in Steroid-refractory Acute Gastrointestinal Graft Versus Host Disease (NCT04768907)MaaT Pharma

Track Steroid Refractory GVHD automatically

Every clearance here is in the API, with alerts when new ones post.